Jefferies Downgrades Aegerion Pharmaceuticals To Hold


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Analysts at Jefferies downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Buy to Hold.The price target for Aegerion Pharmaceuticals has been lowered from $61.00 to $24.00. Aegerion Pharmaceuticals shares have dropped 58.68% over the past 52 weeks, while the S&P 500 index has surged 13.56% in the same period.Aegerion Pharmaceuticals' shares fell 31.28% to $23.51 in pre-market trading.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: DowngradesAnalyst RatingsJefferies